Meningeal metastasis patients with EGFR G724S who develop resistance to osimertinib benefit from the addition of afatinib

Meningeal metastasis patients with EGFR G724S who develop resistance to osimertinib benefit from the addition of afatinib

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Translational lung cancer research 2020-10, Vol.9 (5), p.2188-2190
Hauptverfasser: Li, Yibin, Lin, Yantang, Wu, Jingxun, Ye, Feng
Format: Artikel
Sprache:eng
Schlagworte:
Letter to the Editor
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2190
container_issue 5
container_start_page 2188
container_title Translational lung cancer research
container_volume 9
creator Li, Yibin
Lin, Yantang
Wu, Jingxun
Ye, Feng
description
doi_str_mv 10.21037/tlcr-20-847
format Article
fullrecord <record><control><sourceid>pubmedcentral_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7653111</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_7653111</sourcerecordid><originalsourceid>FETCH-LOGICAL-c361t-a63e7059106ca4e974de68e228a75c2365263cd9454733922a0e56a8ab6d54053</originalsourceid><addsrcrecordid>eNpVkd1KxDAQhYMo7qLe-QB5AKv5T3sjyKKroAj-XIdpO92NtM2SRBff3q6KIAzMwDnzweEQcsrZueBM2ovcN7EQrCiV3SNzIYQplLJ2f3fzsjBW8xk5SemNMcZVpbSuDslMSsEqo_icfD7g6McVQk8HzJCm8YluIHscc6Jbn9f0ennzRJdWqGe6XQfa4gf2YUMjTtYMY4M0BxqSHzBmP_qa1jhi5zPtYhhoXiOFtvXZh5GGjkIH365jctBBn_Dkdx-R15vrl8Vtcf-4vFtc3ReNNDwXYCRapivOTAMKK6taNCUKUYLVjZBGCyObdkqmrJSVEMBQGyihNq1WTMsjcvnD3bzXA7bNlCtC7zbRDxA_XQDv_iujX7tV-HDWaMk5nwBnP4AmhpQidn-_nLnvFtyuBSeYm1qQX6Rzez4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Meningeal metastasis patients with EGFR G724S who develop resistance to osimertinib benefit from the addition of afatinib</title><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Li, Yibin ; Lin, Yantang ; Wu, Jingxun ; Ye, Feng</creator><creatorcontrib>Li, Yibin ; Lin, Yantang ; Wu, Jingxun ; Ye, Feng</creatorcontrib><identifier>ISSN: 2218-6751</identifier><identifier>EISSN: 2226-4477</identifier><identifier>DOI: 10.21037/tlcr-20-847</identifier><identifier>PMID: 33209641</identifier><language>eng</language><publisher>AME Publishing Company</publisher><subject>Letter to the Editor</subject><ispartof>Translational lung cancer research, 2020-10, Vol.9 (5), p.2188-2190</ispartof><rights>2020 Translational Lung Cancer Research. All rights reserved. 2020 Translational Lung Cancer Research.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c361t-a63e7059106ca4e974de68e228a75c2365263cd9454733922a0e56a8ab6d54053</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653111/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653111/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids></links><search><creatorcontrib>Li, Yibin</creatorcontrib><creatorcontrib>Lin, Yantang</creatorcontrib><creatorcontrib>Wu, Jingxun</creatorcontrib><creatorcontrib>Ye, Feng</creatorcontrib><title>Meningeal metastasis patients with EGFR G724S who develop resistance to osimertinib benefit from the addition of afatinib</title><title>Translational lung cancer research</title><subject>Letter to the Editor</subject><issn>2218-6751</issn><issn>2226-4477</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNpVkd1KxDAQhYMo7qLe-QB5AKv5T3sjyKKroAj-XIdpO92NtM2SRBff3q6KIAzMwDnzweEQcsrZueBM2ovcN7EQrCiV3SNzIYQplLJ2f3fzsjBW8xk5SemNMcZVpbSuDslMSsEqo_icfD7g6McVQk8HzJCm8YluIHscc6Jbn9f0ennzRJdWqGe6XQfa4gf2YUMjTtYMY4M0BxqSHzBmP_qa1jhi5zPtYhhoXiOFtvXZh5GGjkIH365jctBBn_Dkdx-R15vrl8Vtcf-4vFtc3ReNNDwXYCRapivOTAMKK6taNCUKUYLVjZBGCyObdkqmrJSVEMBQGyihNq1WTMsjcvnD3bzXA7bNlCtC7zbRDxA_XQDv_iujX7tV-HDWaMk5nwBnP4AmhpQidn-_nLnvFtyuBSeYm1qQX6Rzez4</recordid><startdate>202010</startdate><enddate>202010</enddate><creator>Li, Yibin</creator><creator>Lin, Yantang</creator><creator>Wu, Jingxun</creator><creator>Ye, Feng</creator><general>AME Publishing Company</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>202010</creationdate><title>Meningeal metastasis patients with EGFR G724S who develop resistance to osimertinib benefit from the addition of afatinib</title><author>Li, Yibin ; Lin, Yantang ; Wu, Jingxun ; Ye, Feng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c361t-a63e7059106ca4e974de68e228a75c2365263cd9454733922a0e56a8ab6d54053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Letter to the Editor</topic><toplevel>online_resources</toplevel><creatorcontrib>Li, Yibin</creatorcontrib><creatorcontrib>Lin, Yantang</creatorcontrib><creatorcontrib>Wu, Jingxun</creatorcontrib><creatorcontrib>Ye, Feng</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Translational lung cancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Yibin</au><au>Lin, Yantang</au><au>Wu, Jingxun</au><au>Ye, Feng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Meningeal metastasis patients with EGFR G724S who develop resistance to osimertinib benefit from the addition of afatinib</atitle><jtitle>Translational lung cancer research</jtitle><date>2020-10</date><risdate>2020</risdate><volume>9</volume><issue>5</issue><spage>2188</spage><epage>2190</epage><pages>2188-2190</pages><issn>2218-6751</issn><eissn>2226-4477</eissn><pub>AME Publishing Company</pub><pmid>33209641</pmid><doi>10.21037/tlcr-20-847</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2218-6751
ispartof Translational lung cancer research, 2020-10, Vol.9 (5), p.2188-2190
issn 2218-6751
2226-4477
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7653111
source EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Letter to the Editor
title Meningeal metastasis patients with EGFR G724S who develop resistance to osimertinib benefit from the addition of afatinib
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T12%3A27%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Meningeal%20metastasis%20patients%20with%20EGFR%20G724S%20who%20develop%20resistance%20to%20osimertinib%20benefit%20from%20the%20addition%20of%20afatinib&rft.jtitle=Translational%20lung%20cancer%20research&rft.au=Li,%20Yibin&rft.date=2020-10&rft.volume=9&rft.issue=5&rft.spage=2188&rft.epage=2190&rft.pages=2188-2190&rft.issn=2218-6751&rft.eissn=2226-4477&rft_id=info:doi/10.21037/tlcr-20-847&rft_dat=%3Cpubmedcentral_cross%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_7653111%3C/pubmedcentral_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/33209641&rfr_iscdi=true